IVAX and Biomerica team up for diagnostics
This article was originally published in Clinica
Executive Summary
IVAX Diagnostics is to enhance its existing offering of ELISA (enzyme-linked immunosorbent assay) products and expand its entry into the $10.3bn rapid point-of-care testing market by becoming the distributor of Biomerica’s diagnostic tests.